A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01271
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Enabling and Disabling Polo-Like Kinase 1 Inhibition Through Chemical Genetics

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2012English

PLK1 (Polo-Like Kinase 1 (Drosophila))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Lymphoma
2013English

A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Targeting Polo-Like Kinase 1, a Regulator of P53, in the Treatment of Adrenocortical Carcinoma

Clinical and Translational Medicine
MedicineMolecular Medicine
2016English

Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2010English

Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Regulating a Key Mitotic Regulator, Polo-Like Kinase 1 (PLK1)

Cytoskeleton
Cell BiologyStructural Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy